Vibativ: payments to doctors
Payments that named Vibativ as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.2M
- Providers
- 1,696
- Transactions
- 6,850
- Average per transaction
- $180
The per-transaction average — $180 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,696 providers the average total is $727, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Cumberland Pharmaceuticals, Inc. | $1,231,011 | 99.9% |
| Verity Pharmaceuticals Inc. | $1,626 | 0.1% |